Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2024
|
| Schlagworte: | |
| Online-Zugang: | https://arxiv.org/abs/2409.04933 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866917777605918720 |
|---|---|
| author | Liu, Jiewen Miano, Todd A. Griffiths, Stephen Shashaty, Michael G. S. Yang, Wei |
| author_facet | Liu, Jiewen Miano, Todd A. Griffiths, Stephen Shashaty, Michael G. S. Yang, Wei |
| contents | Marginal structural models (MSMs) are widely used in observational studies to estimate the causal effect of time-varying treatments. Despite its popularity, limited attention has been paid to summarizing the treatment history in the outcome model, which proves particularly challenging when individuals' treatment trajectories exhibit complex patterns over time. Commonly used metrics such as the average treatment level fail to adequately capture the treatment history, hindering causal interpretation. For scenarios where treatment histories exhibit distinct temporal patterns, we develop a new approach to parameterize the outcome model. We apply latent growth curve analysis to identify representative treatment trajectories from the observed data and use the posterior probability of latent class membership to summarize the different treatment trajectories. We demonstrate its use in parameterizing the MSMs, which facilitates the interpretations of the results. We apply the method to analyze data from an existing cohort of lung transplant recipients to estimate the effect of Tacrolimus concentrations on the risk of incident chronic kidney disease. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2409_04933 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | Marginal Structural Modeling of Representative Treatment Trajectories Liu, Jiewen Miano, Todd A. Griffiths, Stephen Shashaty, Michael G. S. Yang, Wei Methodology Marginal structural models (MSMs) are widely used in observational studies to estimate the causal effect of time-varying treatments. Despite its popularity, limited attention has been paid to summarizing the treatment history in the outcome model, which proves particularly challenging when individuals' treatment trajectories exhibit complex patterns over time. Commonly used metrics such as the average treatment level fail to adequately capture the treatment history, hindering causal interpretation. For scenarios where treatment histories exhibit distinct temporal patterns, we develop a new approach to parameterize the outcome model. We apply latent growth curve analysis to identify representative treatment trajectories from the observed data and use the posterior probability of latent class membership to summarize the different treatment trajectories. We demonstrate its use in parameterizing the MSMs, which facilitates the interpretations of the results. We apply the method to analyze data from an existing cohort of lung transplant recipients to estimate the effect of Tacrolimus concentrations on the risk of incident chronic kidney disease. |
| title | Marginal Structural Modeling of Representative Treatment Trajectories |
| topic | Methodology |
| url | https://arxiv.org/abs/2409.04933 |